Extended follow-up of CD4+ T cell recovery kinetics in a large cohort of patients with B-cell lymphoproliferative disease treated with rituximab-bendamustine

Hematol Oncol. 2021 Feb;39(1):137-140. doi: 10.1002/hon.2797. Epub 2020 Sep 4.
No abstract available

Keywords: CD4 lymphopenia; bendamustine; chronic lymphocytic leukemia; non-Hodgkin lymphoma.

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Bendamustine Hydrochloride / administration & dosage
  • CD4 Lymphocyte Count
  • CD4-Positive T-Lymphocytes / metabolism*
  • Female
  • Follow-Up Studies
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / blood*
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Male
  • Middle Aged
  • Recovery of Function / drug effects*
  • Rituximab / administration & dosage

Substances

  • Rituximab
  • Bendamustine Hydrochloride